Skip to main content
BBIO
NASDAQ Life Sciences

FDA Grants Priority Review for BridgeBio's BBP-418 NDA, Sets Nov. 27 PDUFA Date

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$66.44
Mkt Cap
$13.013B
52W Low
$31.77
52W High
$84.94
52W Position info
109% above low
Off High info
22% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

BBIO has more than doubled off its 52-week low of $31.77.

Summary

The FDA has granted Priority Review for BridgeBio's BBP-418 New Drug Application (NDA) for LGMD2I/R9, setting a PDUFA date of November 27, 2026. This follows positive Phase 3 results announced in March and the NDA submission later that month, as well as an 8-K filed today. Priority Review accelerates the FDA's decision timeline and signals the agency's view that BBP-418 could be a significant therapeutic advance. If approved, it would be the first treatment for LGMD2I/R9, a rare genetic muscle disorder. The PDUFA date in November is the next critical milestone.

At the time of this announcement, BBIO was trading at $66.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13B. The 52-week trading range was $31.77 to $84.94. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

BBIO - Latest Insights

BBIO
Oct 13, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $65.75
Real-time Price: $69.37 info
Change: +$3.62 (+6%) info
Market Cap: $13.561B info
BBIO
Oct 11, 2026, 2:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $65.35
Real-time Price: $69.37 info
Change: +$4.02 (+6%) info
Market Cap: $13.561B info
BBIO
Oct 11, 2026, 11:42 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $65.35
Real-time Price: $69.37 info
Change: +$4.02 (+6%) info
Market Cap: $13.561B info
BBIO
Oct 06, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $66.39
Real-time Price: $69.37 info
Change: +$2.98 (+4%) info
Market Cap: $13.561B info
BBIO
Oct 05, 2026, 7:40 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $67.98
Real-time Price: $69.37 info
Change: +$1.39 (+2%) info
Market Cap: $13.561B info